Frequently Asked Questions
Advancing Regenerative Medicine
What is the AmnioGenic Therapy™
AmnioGenic Therapy™ is the novel concept of the use of amnion-derived allograft in the management of soft-tissue defects, chronic wounds, as a soft-tissue covering or localized points of inflammation. AmnioGenic Therapy™ is provided exclusively by Applied Biologics™ and does not make reference to a specific product, trademarked or otherwise, manufacturer or supplier of amnion-derived products.
Description:
- Human allograft regulated by the FDA under 21 CFR Part 1271 and Section 361 of the Public Health Service Act
- Tissue procured from live, healthy donors during scheduled Caesarian section
- Provides a structural matrix for use as a soft-tissue defect covering and localized areas of inflammation